Inactive Instrument

Other languages Green Cross Cell Corporation

Equities

A031390

KR7031390008

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Green Cross Cell Corporation(KOSDAQ:A031390) dropped from S&P Global BMI Index	18/11/21
Green Cross Lab Cell Corporation completed the acquisition of Green Cross Cell Corporation from a group of shareholders.	26/10/21
Green Cross Lab Cell Corporation entered into a definitive merger agreement to acquire Green Cross Cell Corporation from a group of shareholders for approximately KRW 510 billion.	15/07/21
Tranche Update on Green Cross Cell corporation's Equity Buyback Plan announced on March 20, 2019.	12/04/19
Green Cross Cell corporation's Equity Buyback announced on March 20, 2019, has closed with 40,000 shares, representing 0.34% for KRW 2,001.4 million.	10/04/19
Green Cross Cell corporation announces an Equity Buyback for 40,000 shares.	20/03/19
Green Cross Cell corporation authorizes a Buyback Plan.	19/03/19
Sistema, Medsi and RDIF Sign Agreement with South Korean Biotechnology Company Green Cross Cell	11/09/18
An undisclosed buyer cancelled the acquisition of Korea High Tech Co., Ltd. from Green Cross Cell corporation.	06/09/18
Green Cross Cell corporation completed the acquisition of additional 68.8% stake in Lymphotec, Inc. from Toyo Seikan Group Holdings, Ltd..	29/04/18
Green Cross Cell corporation agreed to acquire additional 68.8% stake in Lymphotec, Inc. from Toyo Seikan Group Holdings, Ltd..	29/03/18
Green Cross Cell corporation cancelled the acquisition of CT (cell therapy) business from Green Cross Corporation.	22/02/18
Green Cross Cell corporation announced that it has received KRW 60 billion in funding from a group of investors	28/11/17
AroCell AB Signs Letter of Intent with Green Cross Cell Corporation	22/11/17
Green Cross Cell corporation announced that it expects to receive KRW 60 billion in funding from a group of investors	19/11/17
An undisclosed buyer agreed to acquire Korea High Tech Co., Ltd. from Green Cross Cell corporation for KRW 2.6 billion.	06/09/17
Green Cross Cell corporation's Equity Buyback announced on February 23, 2017, has expired.	05/04/17
Green Cross Cell corporation announces an Equity Buyback.	23/02/17
Green Cross Cell corporation authorizes a Buyback Plan.	22/02/17
Green Cross Cell corporation signed an agreement to acquire CT (cell therapy) business from Green Cross Corporation for KRW 7.9 billion.	22/02/17

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Green Cross Cell Corporation

Equities

A031390

KR7031390008

Other languages

Filters